{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T19:03:13Z","timestamp":1784919793400,"version":"3.55.0"},"reference-count":43,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2020,11,20]],"date-time":"2020-11-20T00:00:00Z","timestamp":1605830400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Institute for Health Research Collaboration for Leadership in Applied Health Research and Care for South Yorkshire","award":["."],"award-info":[{"award-number":["."]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJNS"],"abstract":"<jats:p>Glutaric aciduria type 1, homocystinuria, isovaleric acidaemia, long-chain hydroxyacyl CoA dehydrogenase deficiency and maple syrup urine disease are all inborn errors of metabolism that can be detected through newborn bloodspot screening. This evaluation was undertaken in 2013 to provide evidence to the UK National Screening Committee for the cost-effectiveness of including these five conditions in the UK Newborn Bloodspot Screening Programme. A decision-tree model with lifetable estimates of outcomes was built with the model structure and parameterisation informed by a systematic review and expert clinical judgment. A National Health Service\/Personal Social Services perspective was used, and lifetime costs and quality-adjusted life years (QALYs) were discounted at 1.5%. Uncertainty in the results was explored using expected value of perfect information analysis methods together with a sensitivity analysis using the screened incidence rate in the UK from 2014 to 2018. The model estimates that screening for all the conditions is more effective and cost saving when compared to not screening for each of the conditions, and the results were robust to the updated incidence rates. The key uncertainties included the sensitivity and specificity of the screening test and the estimated costs and QALYs.<\/jats:p>","DOI":"10.3390\/ijns6040093","type":"journal-article","created":{"date-parts":[[2020,11,23]],"date-time":"2020-11-23T01:28:48Z","timestamp":1606094928000},"page":"93","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["The Cost-Effectiveness of Expanding the UK Newborn Bloodspot Screening Programme to Include Five Additional Inborn Errors of Metabolism"],"prefix":"10.3390","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7677-0309","authenticated-orcid":false,"given":"Alice","family":"Bessey","sequence":"first","affiliation":[{"name":"School of Health and Related Research, the University of Sheffield, Sheffield S1 4DA, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1231-7817","authenticated-orcid":false,"given":"James","family":"Chilcott","sequence":"additional","affiliation":[{"name":"School of Health and Related Research, the University of Sheffield, Sheffield S1 4DA, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2552-5260","authenticated-orcid":false,"given":"Abdullah","family":"Pandor","sequence":"additional","affiliation":[{"name":"School of Health and Related Research, the University of Sheffield, Sheffield S1 4DA, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1739-6852","authenticated-orcid":false,"given":"Suzy","family":"Paisley","sequence":"additional","affiliation":[{"name":"School of Health and Related Research, the University of Sheffield, Sheffield S1 4DA, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,11,20]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1542\/peds.109.1.99","article-title":"Long-Chain 3-Hydroxyacyl-CoA Dehydrogenase Deficiency: Clinical Presentation and Follow-Up of 50 Patients","volume":"109","author":"Boer","year":"2002","journal-title":"Pediatrics"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1750-1172-7-9","article-title":"Clinical and neurocognitive outcome in symptomatic isovaleric acidemia","volume":"7","author":"Wendel","year":"2012","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_3","first-page":"1","article-title":"The natural history of homocystinuria due to cystathionine beta-synthase deficiency","volume":"37","author":"Mudd","year":"1985","journal-title":"Am. J. Hum. Genet."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s10545-010-9244-x","article-title":"Urgent metabolic service improves survival in long-chain 3-hydroxyacyl-CoA dehydrogenase (LCHAD) deficiency detected by symptomatic identification and pilot newborn screening","volume":"34","author":"Gradowska","year":"2011","journal-title":"J. Inherit. Metab. Dis."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1007\/s10545-006-0315-y","article-title":"Maple syrup urine disease: Favourable effect of early diagnosis by newborn screening on the neonatal course of the disease","volume":"29","author":"Simon","year":"2006","journal-title":"J. Inherit. Metab. Dis."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1203\/01.pdr.0000219387.79887.86","article-title":"Natural History, Outcome, and Treatment Efficacy in Children and Adults with Glutaryl-CoA Dehydrogenase Deficiency","volume":"59","author":"Garbade","year":"2006","journal-title":"Pediatr. Res."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1056\/NEJMoa025225","article-title":"Screening Newborns for Inborn Errors of Metabolism by Tandem Mass Spectrometry","volume":"348","author":"Wilcken","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"ref_8","unstructured":"Burton, H., and Moorthie, S. (2010). Expanded Newborn Screening: A Review of the Evidence, The PHG Foundation (Foundation for Genomics and Population Health)."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"g3267","DOI":"10.1136\/bmj.g3267","article-title":"Newborn babies will be tested for four more disorders, committee decides","volume":"348","author":"Hawkes","year":"2014","journal-title":"BMJ"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/ejhg.2016.126","article-title":"International differences in the evaluation of conditions for newborn bloodspot screening: A review of scientific literature and policy documents","volume":"25","author":"Jansen","year":"2016","journal-title":"Eur. J. Hum. Genet."},{"key":"ref_11","unstructured":"Public Health England (2020, October 01). Newborn Blood Spot Screening Programme in the UK: Data Collection and Performance Analysis Report 2016 to 2017, Available online: https:\/\/www.gov.uk\/government\/publications\/newborn-blood-spot-screening-data-collection-and-performance-analysis-report."},{"key":"ref_12","unstructured":"Public Health England (2020, October 01). Newborn Blood Spot Screening Programme in the UK: Data Collection and Performance Analysis Report 2017 to 2018, Available online: https:\/\/www.gov.uk\/government\/publications\/newborn-blood-spot-screening-data-collection-report-2017-to-2018."},{"key":"ref_13","unstructured":"National Institute for Health and Care Excellence (2012). Methods for the Development of NICE Public Health Guidance, National Institute for Health and Care Excellence. [3rd ed.]."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1007\/s10545-014-9729-0","article-title":"Systematic review and meta-analysis to estimate the birth prevalence of five inherited metabolic diseases","volume":"37","author":"Moorthie","year":"2014","journal-title":"J. Inherit. Metab. Dis."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1203\/PDR.0b013e318137a124","article-title":"Decline of Acute Encephalopathic Crises in Children with Glutaryl-CoA Dehydrogenase Deficiency Identified by Newborn Screening in Germany","volume":"62","author":"Garbade","year":"2007","journal-title":"Pediatr. Res."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1086\/426318","article-title":"A Common Mutation Is Associated with a Mild, Potentially Asymptomatic Phenotype in Patients with Isovaleric Acidemia Diagnosed by Newborn Screening","volume":"75","author":"Ensenauer","year":"2004","journal-title":"Am. J. Hum. Genet."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1023\/A:1008929526011","article-title":"WinBUGS\u2014A Bayesian modelling framework: Concepts, structure, and extensibility","volume":"10","author":"Lunn","year":"2000","journal-title":"Stat. Comput."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/eye.1998.100","article-title":"Ophthalmic abnormalities in homocystinuria: The value of screening","volume":"12","author":"Taylor","year":"1998","journal-title":"Eye"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1023\/A:1010525528842","article-title":"The intellectual abilities of early-treated individuals with pyridoxine-nonresponsive homocystinuria due to cystathionine \u03b2-synthase deficiency","volume":"24","author":"Yap","year":"2001","journal-title":"J. Inherit. Metab. Dis."},{"key":"ref_20","unstructured":"Curtis, L. (2012). Unit Costs of Health and Social Care 2012, University of Kent."},{"key":"ref_21","unstructured":"Department of Health (2012, July 04). NHS Reference Costs 2011 to 2012, Available online: https:\/\/www.gov.uk\/government\/publications\/nhs-reference-costs-financial-year-2011-to-2012."},{"key":"ref_22","unstructured":"Sheffield Children\u2019s Hospitals NHS Foundation Trust (2012, February 13). Expanded Newborn Screening. Available online: http:\/\/www.expandedscreening.org\/site\/home\/start.asp."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1097\/PCC.0b013e3181c83737","article-title":"BNF for Children 2009 by Paediatric Formulary Committee","volume":"11","author":"Vetterly","year":"2010","journal-title":"Pediatr. Crit. Care Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0895-4356(98)00163-2","article-title":"The Effect of Adding a Cognitive Dimension to the EuroQol Multiattribute Health-Status Classification System","volume":"52","author":"Krabbe","year":"1999","journal-title":"J. Clin. Epidemiol."},{"key":"ref_25","unstructured":"Kind, P., Hardman, G., and Macran, S. (1999). UK Population Norms for EQ-5D, Centre for Health Economics, University of York."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1161\/hq1201.100225","article-title":"Vascular Outcome in Patients with Homocystinuria due to Cystathionine \u03b2-Synthase Deficiency Treated Chronically","volume":"21","author":"Yap","year":"2001","journal-title":"Arter. Thromb. Vasc. Biol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jval.2018.11.001","article-title":"EQ-5D-Y as a Health-Related Quality of Life Instrument for Children and Adolescents: The Instrument\u2019s Characteristics, Development, Current Use, and Challenges of Developing Its Value Set","volume":"22","author":"Kreimeier","year":"2019","journal-title":"Value Health"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta17210","article-title":"A cluster randomised controlled trial of a manualised cognitive behavioural anger management intervention delivered by supervised lay therapists to people with intellectual disabilities","volume":"17","author":"Willner","year":"2013","journal-title":"Health Technol. Assess."},{"key":"ref_29","first-page":"106","article-title":"Incidence of maple syrup urine disease, propionic acidemia, and methylmalonic aciduria from newborn screening data","volume":"15","author":"Chapman","year":"2018","journal-title":"Mol. Genet. Metab. Rep."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1002\/jmd2.12124","article-title":"Evaluation of 11 years of newborn screening for maple syrup urine disease in the Netherlands and a systematic review of the literature: Strategies for optimization","volume":"54","author":"Stroek","year":"2020","journal-title":"JIMD Rep."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1186\/1750-1172-8-167","article-title":"Newborn screening by tandem mass spectrometry for glutaric aciduria type 1: A cost-effectiveness analysis","volume":"8","author":"Pfeil","year":"2013","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.jval.2012.02.007","article-title":"Cost-Effectiveness of Expanded Newborn Screening in Texas","volume":"15","author":"Tiwana","year":"2012","journal-title":"Value Health"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"S287","DOI":"10.1542\/peds.2005-2633H","article-title":"Comprehensive Cost-Utility Analysis of Newborn Screening Strategies","volume":"117","author":"Carroll","year":"2006","journal-title":"Pediatrics"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1111\/j.1651-2227.2005.tb02056.x","article-title":"Expanding screening for rare metabolic disease in the newborn: An analysis of costs, effect and ethical consequences for decision-making in Finland","volume":"94","author":"Sintonen","year":"2005","journal-title":"Acta Paediatr."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1524-4733.2006.00156.x","article-title":"The Cost-Effectiveness of Expanding Newborn Screening for up to 21 Inherited Metabolic Disorders Using Tandem Mass Spectrometry: Results from a Decision-Analytic Model","volume":"10","author":"Cipriano","year":"2007","journal-title":"Value Health"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1067\/mpd.2002.128116","article-title":"Newborn screening with tandem mass spectrometry: Examining its cost-effectiveness in the Wisconsin Newborn Screening Panel","volume":"141","author":"Insinga","year":"2002","journal-title":"J. Pediatr."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1542\/peds.2008-0911","article-title":"Economic Evaluation of Tandem Mass Spectrometry Newborn Screening in Australia","volume":"123","author":"Norman","year":"2009","journal-title":"Pediatrics"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1542\/peds.110.4.781","article-title":"Cost-Benefit Analysis of Universal Tandem Mass Spectrometry for Newborn Screening","volume":"110","author":"Schoen","year":"2002","journal-title":"Pediatrics"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Thiboonboon, K., Leelahavarong, P., Wattanasirichaigoon, D., Vatanavicharn, N., Wasant, P., Shotelersuk, V., Pangkanon, S., Kuptanon, C., Chaisomchit, S., and Teerawattananon, Y. (2015). An Economic Evaluation of Neonatal Screening for Inborn Errors of Metabolism Using Tandem Mass Spectrometry in Thailand. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0134782"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s10545-015-9907-8","article-title":"Impact of age at onset and newborn screening on outcome in organic acidurias","volume":"39","author":"Heringer","year":"2016","journal-title":"J. Inherit. Metab. Dis."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.ejpn.2015.07.009","article-title":"Evolution of maple syrup urine disease in patients diagnosed by newborn screening versus late diagnosis","volume":"19","author":"Couce","year":"2015","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.jcma.2016.07.006","article-title":"Experiences during newborn screening for glutaric aciduria type 1: Diagnosis, treatment, genotype, phenotype, and outcomes","volume":"80","author":"Tsai","year":"2017","journal-title":"J. Chin. Med. Assoc."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.ymgme.2012.05.024","article-title":"Glutaric acidemia Type 1: Outcomes before and after expanded newborn screening","volume":"106","author":"Viau","year":"2012","journal-title":"Mol. Genet. Metab."}],"container-title":["International Journal of Neonatal Screening"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2409-515X\/6\/4\/93\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:35:11Z","timestamp":1760178911000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2409-515X\/6\/4\/93"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,20]]},"references-count":43,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["ijns6040093"],"URL":"https:\/\/doi.org\/10.3390\/ijns6040093","relation":{},"ISSN":["2409-515X"],"issn-type":[{"value":"2409-515X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,20]]}}}